Press Releases

NEW YORK, Oct. 23, 2026 (GLOBE NEWSWIRE) -- WeShop Holdings Limited ("WeShop" or the "Company") (NASDAQ:WSHP), the community-owned shopping app on a mission to make shopping more rewarding, today announced that eligible UK members participating in the WeShop ShareBack™ Rewards Plan (the "ShareBack Plan") will be able to begin claiming the Company’s Class A ordinary shares on November 23, marking one year since WeShop’s Nasdaq listing. Members earn WePoints every time they shop with WeShop's retail partners. Under the ShareBack Plan, eligible members can now turn those WePoints into the Company’s Class A ordinary shares. Everyday shopping can now build ownership in the business members hel

MAHIA, New Zealand, Oct. 23, 2026 (GLOBE NEWSWIRE) -- Rocket Lab Corporation (NASDAQ:RKLB), a global leader in launch services and space systems, today launched its Electron rocket to deliver a dedicated mission to space for HawkEye 360, a signals intelligence data and analytics company. The ‘We're Not Hawking Around’ mission launched from Rocket Lab Launch Complex 1 in New Zealand at 8:11 p.m. NZDT on 23 October 2026, to deliver three HAWK satellites to a 520km low Earth orbit. Operating in tri-satellite formation, HawkEye 360's satellites collect signal data from across the radio frequency (RF) spectrum for maritime tracking, GNSS jamming detection, radar monitoring, communications mapp

FLORHAM PARK, N.J., Oct. 23, 2026 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT), a biopharmaceutical company focused on commercializing and developing novel treatments for gastrointestinal (GI) diseases, announced today that BDR Pharmaceuticals International Pvt. Ltd. (BDR) has filed suit against the U.S. Food and Drug Administration (FDA) and related Federal Defendants in the United States District Court for the District of Columbia, principally challenging FDA’s alleged refusal to receive an abbreviated new drug application (ANDA) referencing Phathom’s new drug application (NDA) for VOQUEZNA®. In the suit, BDR alleges that FDA has improperly applied the GAIN Act to exte

SOUTH SAN FRANCISCO, Calif., Oct. 23, 2026 (GLOBE NEWSWIRE) -- Veracyte, Inc. (NASDAQ:VCYT), a leading cancer diagnostics company, today announced new data showing that its Decipher® Prostate Genomic Classifier can predict benefit from adding abiraterone to androgen deprivation therapy (ADT) in men with clinically very high-risk nonmetastatic prostate cancer. The findings will be presented tomorrow in a proffered paper oral presentation at the European Society for Medical Oncology (ESMO) Congress 2026 by Dr. Sarah Howlett of University College London (UCL). The retrospective analysis of the randomized Phase III STAMPEDE trial provides new Level 1B predictive evidence for Decipher in men

- Initial Phase 1b results show mean reduction of cerebrospinal fluid mutant huntingtin of 60 to 64% at month 3 with individual reduction of up to 83% and encouraging safety and tolerability with potential for twice yearly dosing - - Unique targeting approach reduces both mutant huntingtin and shorter mutant HTT1a- - Placebo-controlled pivotal study planned for 2027, pending regulatory alignment - - Alnylam to discuss Huntington’s disease program at October 26 RNAi Roundtable - Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY), the leading RNAi therapeutics company, today reported positive initial Phase 1b clinical trial results for ALN-HTT02, an investigational RNAi therapeutic in develo

Preclinical data highlight potential advantages of targeting PRC2 via EED over EZH2, including the emergence of resistance mutations to EZH2 inhibitors like mevrometostat and against which the EED inhibitor rinzimetostat maintained effectiveness Preclinical results, supported by translational data in mCRPC patient samples, show rinzimetostat reinforces a luminal, AR-dependent state, restricts lineage plasticity and enhances sensitivity to AR inhibition Findings reinforce rinzimetostat’s differentiated profile and support development across the prostate cancer disease spectrum, including in the ongoing Himalayas-1 Phase 3 trial SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Oct. 23, 2026 (G

In a 1L EGFR atypical population with more than double the rate of baseline CNS metastases as competitor datasets, enozertinib demonstrates a potential best-in-class 84% confirmed systemic ORR and 70% confirmed intracranial ORR, with multiple intracranial complete responses 88% 6-month landmark PFS compares favorably to current standards of care and to investigational therapies; follow-up ongoing with majority of patients continuing on treatment Competitive safety profile with no significant off-target toxicity and no treatment-related discontinuations Redwood-1 global Phase 3 registrational trial initiation in 1L EGFR atypical NSCLC expected in 1H 2027 Company to host a conference call

EVX-01 induced an immune response in all patients in the trial with 89% of the vaccine neoantigens generating potent specific T-cell responses Three-year data from the EVX-01 phase 2 trial in patients with advanced melanoma to be presented at the ESMO 2026 Congress supplementing very convincing two-year data from the trialThe data will be presented at a poster session on October 24, 2026, followed by a webinar on October 29, 2026, providing further insights into the findings COPENHAGEN, Denmark, October 23, 2026 - Evaxion A/S (NASDAQ:EVAX) ("Evaxion"), a clinical-stage TechBio company developing novel immunotherapies with its pioneering AI-Immunology™ platform, announces new three-year immu

Social commerce, marketplaces and eCommerce players served by LianLian Global can now pay creators, influencers, developers, and independent contractors directly to their PayPal and Venmo wallets.NEW YORK, Oct. 22, 2026 /PRNewswire/ -- LianLian Global  today announced it has partnered with PayPal (NASDAQ:PYPL) to enable its social commerce, marketplace and e-commerce clients to send payouts directly to PayPal accounts globally and to Venmo accounts in the U.S. The creator and gig economy runs on fast, low-friction payouts. Brands are expected to spend $32.6 billion on creators in 2026 and roughly 50 million people worldwide create content professionally or semi-professionally (Gigapay Global

Zai Lab Limited (NASDAQ:ZLAB, HKEX: 9688)) an innovation-driven, global biopharma company, today announced that it has entered into a securities purchase agreement for the sale of 11,340,000 American Depositary Shares ("ADSs"), each representing ten ordinary shares of the Company, to certain investors in a private investment in public equity ("PIPE") financing. The purchase price of each ADS is $22.04. Gross proceeds from the PIPE financing are expected to be approximately $250 million, before deducting placement agent fees and other offering expenses. The PIPE financing is expected to close on or about October 27, 2026, subject to customary closing conditions. The financing is led by TCG

Sensata Technologies (NYSE:ST) today announced that its Board of Directors approved a quarterly dividend in the amount of $0.12 per share. The Company will pay this fourth quarter 2026 dividend on November 25, 2026, to shareholders of record as of November 11, 2026. About Sensata Technologies Sensata Technologies is a global industrial technology company striving to create a safer, cleaner, more efficient and electrified world. Through its broad portfolio of mission-critical sensors, electrical protection components and sensor-rich solutions, Sensata helps its customers address increasingly complex engineering and operating performance requirements. With more than 16,000 employees and g

New Colorado facility strengthens domestic 3D printing production capabilities for aerospace, defense, and semiconductor equipment manufacturers while advancing supply chain resilienceAdds 50,000 sq. foot of production and office space at Littleton, CO. campusIncreases opportunities for workforce development in Colorado region ROCK HILL, S.C., Oct. 22, 2026 (GLOBE NEWSWIRE) -- The listed names beneath the photo in a press release issued yesterday by 3D Systems Inc. have been corrected. The corrected release follows: 3D Systems (NYSE:DDD) today announced the grand opening of its new Industrial Technology Center in Littleton, Colorado, expanding the company's ability to help aerospace, def

Declares Quarterly Cash Dividend of $0.10 Per ShareMCLEAN, Va., Oct. 22, 2026 /PRNewswire/ -- Primis Financial Corp. (NASDAQ:FRST) ("Primis" or the "Company"), and its wholly-owned subsidiary, Primis Bank (the "Bank"), today reported net income available to common shareholders of $8.7 million, or $0.35 per diluted share, for the three months ended September 30, 2026, compared to net income available to common shareholders of $6.8 million, or $0.28 per diluted share, for the three months ended September 30, 2025.  For the nine months ended September 30, 2026, the Company reported net income available to common shareholders of $25.4 million, or $1.03 per diluted share, compared to net income a

ORLANDO, Fla, Oct. 22, 2026 (GLOBE NEWSWIRE) -- MicroVision, Inc. (NASDAQ:MVIS), a leader in advanced perception solutions for industrial, security and defense, intelligent infrastructure, and automotive applications, today announced the much-anticipated commercial production launch of MOVIA™ Pro, shipping sensors to meet customer demand. MOVIA Pro is the company’s next-generation short-range lidar sensor uniquely engineered to deliver differentiated sensing performance and onboard perception capabilities, with flexible integration across intelligent infrastructure, unmanned aerial, industrial robotics, and other emerging autonomous applications.  MVIS)" height="338" src="https://ml.globe

VANCOUVER, British Columbia, Oct. 22, 2026 (GLOBE NEWSWIRE) -- Foremost Clean Energy Ltd. (NASDAQ:FMST) (CSE:FAT) ("Foremost" or the "Company") is pleased to report that it has entered into an agreement with Denison Mines Corp. ("Denison") to sell a 31% interest in the GR and Blackwing properties (together the "Properties"), form two exploration joint ventures ("JVs"), and issue 1,031,191 share purchase warrants (the "Warrants") in exchange for total consideration of $650,000 (collectively, the "Transaction"). The warrants will have an exercise price of $1.80 per warrant share, which represents over a 175% premium to Foremost’s closing share price on October 22, 2026, and will have a 5-yea

NANJING, China, Oct. 22, 2026 /PRNewswire/ -- Scage Future ("Scage Future" or the "Company") (NASDAQ:SCAG), a provider of new energy and zero-emission heavy-duty commercial vehicles and e-fuel solutions, today announced the effective date and new CUSIP number for the previously announced change in the ratio of its American Depositary Shares ("ADSs") to its ordinary shares (the "ADS Ratio"), from the current ADS Ratio of one (1) ADS to one (1) ordinary share to a new ADS Ratio of one (1) ADS to fifteen (15) ordinary shares (the "ADS Ratio Change"). The ADS Ratio Change will be effective on October 27, 2026 (the "Effective Date").

CHICAGO, Oct. 22, 2026 (GLOBE NEWSWIRE) -- XAI Floating Rate & Alternative Income Trust (NYSE:XFLT) (the "Trust") today announced that it plans to host the Trust’s Quarterly Webinar on November 2, 2026, at 3:00 pm (Eastern Time). Kevin Davis, Managing Director at XA Investments will moderate the Q&A style webinar with Kimberly Flynn, President at XA Investments, and Young Choi, Partner and Global Head of Trading at King Street Capital Management. Young Choi also serves as the Portfolio Manager of Rockford Tower Capital Management, King Street’s CLO, CBO and SMA platform. TO JOIN VIA WEB: Please click here to find the online registration link. TO USE YOUR TELEPHONE: After joining via web,

NEW YORK, Oct. 22, 2026 (GLOBE NEWSWIRE) -- Namib Minerals ("Namib" or "the Company") (NASDAQ:NAMM) today announced that its subsidiary, Bulawayo Mining Company (Private) Limited, has signed a nonbinding term sheet with Ecobank Zimbabwe Limited ("Ecobank") for a proposed non-dilutive $30 million, 36-month loan facility (the "Proposed Facility") intended to support Redwing Mine’s resource-definition and bankability programme. The Proposed Facility remains subject to completion of the customary conditions precedent and the execution of definitive documentation. Upon completion of the definitive documentation and satisfaction of the customary conditions precedent, on the proposed terms, the

Bogotá, Colombia, Oct. 22, 2026 (GLOBE NEWSWIRE) -- GeoPark Limited ("GeoPark" or the "Company") (NYSE:GPRK), an exempted company incorporated under the laws of Bermuda, today announced the tender results in connection with its offer to purchase for cash any and all of its outstanding 8.750% Senior Notes due 2030 (the "Notes") (the "Tender Offer"). The Tender Offer was made upon the terms and subject to the conditions (including the Financing Condition (as defined in the Offer to Purchase)) set forth in the offer to purchase dated October 16, 2026 (the "Offer to Purchase"). As previously announced, the expiration time for the Tender Offer was 5:00 p.m., New York City time, on October 22,

CHICAGO, Oct. 22, 2026 (GLOBE NEWSWIRE) -- XAI Madison Equity Premium Income Fund (NYSE:MCN) (the "Fund") today announced that it plans to host the Fund’s Quarterly Webinar on November 5, 2026 at 11:00 am (Eastern Time). Kimberly Flynn, President at XA Investments will moderate the Q&A style webinar with Ray Di Bernardo and Drew Justman, Portfolio Managers at Madison Investments. TO JOIN VIA WEB: Please click here to find the online registration link. TO USE YOUR TELEPHONE: After joining via web, if you prefer to use your phone for audio, you must select that option and call in using a number below, based on your current location. Dial: (312) 626-6799 or (646) 558-8656 or (267) 831-0333